MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy – Markets Insider
MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene TherapyMarkets InsiderSAN FRANCISCO, Jan. 25, 2018 /PRNewswire/ — MultiVir Inc. presented updated data at the annual ASCO-SITC Clinical Immuno-Oncology Symposium dem… Continue reading
